282 Mep (meprobamate-containing Medicine) - Market Withdrawal, Effective October 28, 2013 - For The Public

Recall Summary Meprobamate-containing medicines branded as 282 MEP have been withdrawn from the market across Canada as of October 28, 2013. Meprobamate is a sedative medication that was used to treat anxiety and muscle tension. The withdrawal affects all Canadian consumers who may have this medication.

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2013-08-29

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/a86f26fc-9ac3-4a6d-b651-2d43a8df4fd3